PCN90 Cost-Effectiveness Analysis of Erlotinib Versus Docetaxel, Pemetrexed for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Russia
2011 ◽
Vol 14
(7)
◽
pp. A450
◽
T.T.T. Nguyen
◽
R. Yagudina
◽
A. Kulikov
Yumi Asukai
◽
Amparo Valladares
◽
Carlos Camps
◽
Eifiona Wood
◽
Kaisa Taipale
◽
...
2004 ◽
Vol 22
(9)
◽
pp. 581-589
◽
Jeremy Holmes
◽
David Dunlop
◽
Lindsay Hemmett
◽
Peter Sharplin
◽
Uday Bose
2021 ◽
Vol 38
(10)
◽
pp. 5116-5126
◽
Jinhong Gong
◽
Qian Wan
◽
Jingjing Shang
◽
Xiaodan Qian
◽
Dan Su
◽
...
2011 ◽
Vol 6
(12)
◽
pp. 2097-2103
◽
Ian Cromwell
◽
Kimberly van der Hoek
◽
Barbara Melosky
◽
Stuart Peacock
2016 ◽
Vol 19
(7)
◽
pp. A732-A733
◽
P González García
◽
E Felip
◽
P Garrido
◽
J Trigo
◽
N Ortega-Joaquin
◽
...
AB Fernández Román
◽
C Bravo Lázaro
◽
J Letellez Fernández
◽
N Herrero Muñoz
◽
A Andrés Rosado
◽
...
Yong-Jin Kim
◽
Mark Oremus
◽
Helen H. Chen
◽
Thomas McFarlane
◽
Danielle Fearon
◽
...
2019 ◽
Vol Volume 11
◽
pp. 9195-9202
◽
Maobai Liu
◽
Longfeng Zhang
◽
Qishu Huang
◽
Na Li
◽
Bin Zheng
◽
...
Brendan T. Heiden
◽
Joshua D. Mitchell
◽
Eric Rome
◽
Varun Puri
◽
Bryan F. Meyers
◽
...